OpenAlex
PricingAboutJobs
Log inGet started
Work

Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC–HOVON randomized phase III study (06914)

HTML

Year: 2001
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: British Journal of Haematology
DOI: 10.1046/j.1365-2141.2001.03171.x
Authors: P. Sonneveld, S. Suciu, P. Weijermans, M. Beksac, R. Neuwirtova, G. Solbu, H. Lokhorst, J. Van Der Lelie, H. Dohner, H. Gerhartz, C. M. Segeren, R. Willemze, B. Lowenberg
Institutions: European Organisation for Research and Treatment of Cancer, Erasmus MC, Hovon, Academisch Ziekenhuis Rotterdam
Language: English

Topic: Multiple Myeloma Research and Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: multiple myeloma, refractory multiple myeloma, cyclosporine, VAD chemotherapy, vincristine, doxorubicin, dexamethasone, multidrug resistance reversal, P-glycoprotein, progression-free survival, overall survival, treatment toxicity, bone marrow response
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Awards: G1702825960, G216725516, EORTC HEADQUARTERS, G3709035039, G3977009842, G4006176027, G487334724, G6085286704, G765681649, G927920703
OpenAlex ID: W1972960351
FWCI: 2.002
Cites: 29
Cited by: 101
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security